🎉 Share Your 2025 Year-End Summary & Win $10,000 Sharing Rewards!
Reflect on your year with Gate and share your report on Square for a chance to win $10,000!
👇 How to Join:
1️⃣ Click to check your Year-End Summary: https://www.gate.com/competition/your-year-in-review-2025
2️⃣ After viewing, share it on social media or Gate Square using the "Share" button
3️⃣ Invite friends to like, comment, and share. More interactions, higher chances of winning!
🎁 Generous Prizes:
1️⃣ Daily Lucky Winner: 1 winner per day gets $30 GT, a branded hoodie, and a Gate × Red Bull tumbler
2️⃣ Lucky Share Draw: 10
Many people have asked about the investment logic of a certain biotechnology stock. To be honest, I just want to test the waters with this target. After looking through its financial statements, the data performance is quite good, and it does show signs of being pushed down in price. But look at how much I've actually invested? Doubling it would only yield a 0.6% profit, and halving it would only result in a 0.3% loss—this is not a serious Heavy Position, at best it’s just a small observation Position for fun. If I were to increase it to more than 3% of my total Position, that would indicate that I am really optimistic about it, and then we can dive deeper into discussing this stock. Right now? It’s purely in the trial-and-error stage.